No valuation for Tempo Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($20.7M) and the funding record below are the closest available signals.
- ·The complete investor list: 14 names
- ·Watch Tempo Therapeutics: the Monday email on marks, rounds and moves
Tempo Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2024 | Early Stage VC | $16.3M | ▮ | ▮ |
| Jul 2015 | Seed Round | $3.8M | ▮ | ▮ |
Membership and data by Private Market View
How much has Tempo Therapeutics raised?
Tempo Therapeutics has raised $20.7 million across 2 recorded rounds since 2015. The largest was a $3.8 million seed round in Jul 2015; the most recent was a $16.3 million early-stage round in Mar 2024.
Tempo Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Mar 2024 ($16.3 million sold to 26 investors).
How Tempo Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Tempo Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Tempo Therapeutics
- How much has Tempo Therapeutics raised?
- Tempo Therapeutics has raised $20.7M in total funding across 2 recorded rounds.
- When did Tempo Therapeutics last raise?
- Tempo Therapeutics last raised in Mar 2024 (Early Stage VC), raising $16.3M.